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Signaling pathwayThe vacuolar H+-ATPase (V-ATPase) was ﬁrst identiﬁed as an electrogenic proton pump that acidiﬁes the lumen
of intra- and extracellular compartments. The acidic pH generated by V-ATPase is important for a wide range of
cellular processes as well as acidiﬁcation-independent processes such as secretion and membrane fusion. In
addition to these housekeeping functions, recent studies implicate V-ATPase in the direct regulation and function
of signaling pathways. In this review, we describe recent ﬁndings on the functions of V-ATPase in growth regu-
lation and tissue physiology.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The vacuolar H+-ATPase (V-ATPase) is an electrogenic proton pump
that acidiﬁes the lumen of intra- and extracellular compartments. More
than 30 years have passed after the ﬁrst discovery of the enzyme from
yeast vacuole membranes [1]. Its presence in yeast indicates that the
enzyme is required for basic cellular physiology; indeed, the enzyme
is considered as having a housekeeping function. V-ATPase is now
known to be present in both uni- andmulticellular organisms, including
plants and animals. The enzyme is distributed in various cellular
locations; speciﬁcally, in endomembrane organelles such as the
lysosomes, endosomes, the Golgi apparatus, secretory granules, and
coated vesicles. They are also present in the plasma membrane of
specialized cell types including osteoclasts as well as epithelial cells in
the kidney, male genital tract, and ocular ciliary bodies. The acidic pH
generated by V-ATPase is required for diverse cellular processes includ-
ing endosomal ligand–receptor dissociation, hormone concentration,
lysosomal degradation, and acid secretion (reviewed in [2]). These
ﬁndings indicate that V-ATPase is supporting higher order physiological
processes in themulticellular organisms, in addition to the fundamental
cellular function.
Most recently, V-ATPase is implicated as an essential component of
key signal transduction cascades including Wnt (wingless-related
integration site), Notch, and mTOR (mechanistic or mammalian target
of rapamycin) signaling pathways. These signaling systems, in concert
with one another, regulate cell proliferation/differentiation respondingn-Wada),to extracellular stimulations. This review focuses on the recent advances
in our understanding of V-ATPase function in the signal transduction
systems that enable organisms to acquire a multicellular architecture.
2. Structure of V-ATPase
V-ATPase is a highly conserved multi-subunit enzyme that uses
energy from ATP hydrolysis to transport protons across membranes
[2–4]. It consists of two major functional domains, V1 and V0 (Fig. 1).
The former has eight different subunits (A, B, C, D, E, F, G, andH) and con-
tains three catalytic sites for ATP hydrolysis formed by the A and B sub-
units (A3B3). Themembrane-bound V0 domain is responsible for proton
translocation acrossmembranes; in yeast, it contains up to six subunits:
a, d, and e, and the proteolipids (c, c′, and c″) [5]. Proteolipids are highly
conserved, small four-pass transmembrane proteins that have both
termini in the organelle lumen and form a ring-like structure. Six
proteolipid subunits have been identiﬁed in the ring based on chemical
and cryoelectron microscopy analyses of the bovine-coated vesicle
complex and an electronmicroscopy analysis of theNephrops norvegicus
c ring [2].
Several accessory proteins are associated with the V-ATPase and are
essential for the assembly of the pump complex [6,7]. One of these, Ac
8–9 (Fig. 1), is a truncated form of the (pro)renin receptor encoded by
ATP6ap2. The truncated carboxy terminal fragment M8.9 was found to
be associated with V-ATPase [8], and a recent genetic study of mouse
Atp6ap2 suggests that the full-length protein is essential for complex
assembly [6,9,10]. M8.9 is likely generated by furin cleavage and is
non-functional [11]. As discussed below, the Atp6ap2 protein provides
lines of hot issues, as its function is implicated in multiple signaling
cascades.
Fig. 1. Structure of V-ATPase. The V-ATPase complex is composed of a peripheral domain (V1) responsible for ATP hydrolysis and an integral domain (V0) involved in proton translocation
across the membrane. The core of the V1 domain is composed of a hexameric arrangement of alternating A and B subunits that participate in ATP binding and hydrolysis. The V0 domain
includes a ring of proteolipid subunits (c, c′, and c″) adjacent to subunits a and e. TheV1 andV0 domains are connected by a central stalk composedof subunitsD and F of V1 and subunit d of
V0 as well as multiple peripheral stalks composed of subunits C, E, G, H, and the N-terminal domain of subunit a. Mammalian V-ATPase contains accessory proteins Ac45 and full-length
Atp6ap2 protein, both of which are essential for enzyme function.
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As the primary proton pump that acidiﬁes endosomes and
lysosomes, V-ATPase has been intensively studied for its role in endocy-
tosis [12,13]. Endosomes and lysosomes constitute a highly dynamic
intracellular network that enables the internalization of extracellular
molecules along with a portion of the cell membrane for degradation,
modiﬁcation, and recycling. This process of endocytosis provides a
mechanism for renewing and modifying cell surface and extracellular
components and is common to all eukaryotes. Inhibiting endosomal
acidiﬁcation with V-ATPase-speciﬁc inhibitors or acidotropic agents
affects endocytosis, vesicle trafﬁcking, and the processing of secretory
and lysosomal proteins [14]. This is supported by genetic evidence; for
instance, depletion of V-ATPase in Atp6v0c mutant mice (lacking the
only structural gene for the proteolipid c subunit) affects luminal acidi-
ﬁcation and endocytosis. In addition, V-ATPase-deﬁcient cells exhibit
abnormal Golgi morphology, especially in the trans-region. Genetic
deletion of Atp6v0c results in severe developmental defects in early
embryogenesis at embryonic day 5 [15].
V-ATPase is also involved in a variety of acidiﬁcation-independent
processes [3,4]. The best example is vacuolar assembly, in which
membrane-encircled lysosome-associated organelles fuse to form
larger compartments. This involves a series of biological and physical
events that include recognition of distinctmembrane organelles follow-
ed by membrane fusion, which ultimately leads to the formation of a
single compartment enclosed by a continuous membrane. At the ﬁnal
step of fusion, the trans complex formed by the V0 sectors on the paired
membranes provides the initial point of contact between the two
membranes [16–18]. This step is thought to be independent of canonical
V-ATPase function, i.e., proton translocation and acidiﬁcation. Othermembrane fusion events such as the secretion of insulin-containing
granules and neurotransmitter release at the synapse also require V-
ATPase, but these fusion events were observed when luminal acidiﬁca-
tion was inhibited with baﬁlomycin, a V-ATPase-speciﬁc inhibitor, or
using proton translocation defective mutant [19,20]. On the other
hand, a controversial observation is also reported: the physical presence
of the V-ATPase is not sufﬁcient, but H+-translocation and resulting
vacuole acidiﬁcation are required for vacuole fusion in yeast cells [21].
To elucidate these questions, it may be necessary to use mutations in
V-ATPase V0 subunits that eliminate proton translocation activity
without affecting assembly or targeting of the resulting V-ATPase [21].
Nevertheless, the essential role of V-ATPase in membrane fusion is
undoubtedly.
The acidiﬁcation of endocytic compartments is closely related to
endocytic activity, although the mechanism linking acidiﬁcation and
membrane dynamics is largely unknown. In a recent RNA interference
(RNAi)-based screen, V-ATPase depletion blocked the formation
of clathrin-coated vesicles, an effect that was rescued by adding
exogenous cholesterol [22]; moreover, the time course of cholesterol
depletion from the plasma membrane was correlated with the forma-
tion of coated vesicles. Cells treated with baﬁlomycin for N24 h exhibit-
ed complete loss of transferrin internalization, showing that the V-
ATPase activity is required for the early stage of receptor-mediated
endocytosis [22]. These observations suggest that V-ATPase participates
in the endocytosis by maintaining cholesterol distribution through
recycling the membrane lipids from endosomes back to the plasma
membrane.
However, the V-ATPase knockout phenotype—induced either genet-
ically or pharmacologically—differs from those of cells with impaired
luminal acidiﬁcation. Cells expressing V-ATPase mutants or treated
Fig. 2. ThemTORC1 amino acid sensing pathway. Under low amino acid conditions Ragulator is found in an inhibitory state with the V-ATPase (left). Under sufﬁcient amino acids (right),
V-ATPase triggers Ragulator guanine nucleotide exchange factor activity for Rag GTPase in an amino acid-dependentmanner. Ragulator recruits Rag GTPases to the lysosome. Concurrent-
ly, amino acids promote the GEF activity of Ragulator for GDP-bound RagA and the GAP activity for GTP-bound RagC, and active Rag GTPases can recruit mTORC1 to the lysosome. When
mTORC1 localizes to the lysosome surface, its kinase activity is activated by the small GTPase Rheb, which receives input from growth factor signaling.
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endosomes [23,24], suggesting that acute inhibition of V-ATPase is not
sufﬁcient to block early steps in endocytosis.
Nevertheless, endocytosis plays a regulatory role in multiple signal-
ing pathways, in both positive and negative fashions. A large body of
evidence reveals that the signaling is regulated at different levels and
cellular locations along the endocytic route, as well as at the cell surface
[25]. Thus, endocytic defects resulting from V-ATPase deﬁciency may
result in aberrant signal transduction. However, V-ATPase may
bemore directly involved in the regulation and function of signal trans-
duction. We now describe several key ﬁndings that support this
possibility and discuss the implications for cellular and tissue
physiology.
3.1. mTOR signaling
The Ser/Thr protein kinase mTOR is part of the mTOR complex 1
(mTORC1), which couples amino acid availability to cell growth. Multi-
ple cues including growth factors, stress, energy status, and cellular
amino acid levels modulate mTORC1 activity. In the current model of
the link between V-ATPase and mTOR signaling, V-ATPase triggers theFig. 3. Acidiﬁcation and trafﬁcking inWnt (a) and Notch (b) signaling pathways. Endocytosed e
cellular level of β-catenin ismostly controlled by its ubiquitination and proteosomal degradatio
receptor complex, which requires the V-ATPasemediated acidiﬁcation, inhibits β-catenin phosp
Once β-catenin levels rise high enough, it also translocates into the nucleus, where it activates t
tiated with the binding of the ligand to the single-pass transmembrane receptor Notch, triggeri
followed by γ-secretase, the enzymes prefer the acidic environment for their activity. The Notc
scription. The Notch and its ligand (DSL) are internalized and delivered to endomembrane comguanine nucleotide exchange factor activity of Rag small GTP-binding
protein in an amino acid-dependent manner, which is followed by the
recruitment of mTOR to lysosomal membranes [26]. Upon its localiza-
tion to the lysosome, mTORC1 kinase is activated by the small GTP-
binding protein Rheb, which receives input from growth factor
signaling (Fig. 2). Activated mTOR phosphorylates target molecules
including p70 ribosomal S6 kinase and translation initiation factor 4E-
binding protein, inducing mRNA and protein syntheses. Thus, mTORC1
activation promotes cellular growth by linking it to nutrient availability,
and functions as a key regulatory switch for the decision to proliferate,
differentiate, or undergo cell death.
Importantly, the recruitment and activation of mTORC1 require
lysosomes and V-ATPase. The lysosome is responsible for recycling
amino acids and cellular components via degradation of proteins and
other macromolecules, although acidiﬁcation of the lysosomal lumen
is dispensable for mTORC1 signaling [26]. The main pool of amino
acids associated withmTORC1 activation is imported from the extracel-
lular environment or generated by metabolic processes. Proteins that
are endocytosed and degraded in the lysosome can also provide a
source of amino acids for mTORC1 activation. Although the precise
mechanism remains unclear, a current theory is that the lysosome isndosomesmature into multivesicular bodies (MVB) that fuse with the lysosome. (a), The
n, which depends on the phosphorylation state of β-catenin. Binding ofWnt ligand toWnt
horylation byGSK3, causing its cytosolic substrates such asβ-catenin to become stabilized.
he transcription of target genes. (b), The proteolytic processing that activates Notch is ini-
ng its proteolytic cleavage by a disintegrin and metalloproteinase (ADAM) family member
h intracellular domain (NICD) is released and translocates to the nucleus to regulate tran-
partments. The endocytic trafﬁcking is also required for Notch signal regulation.
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various metabolic pathways—including endocytosis and autophagy—
and therefore provides the best indication of the cell's metabolic state
[27].
Blocking cholesterol trafﬁcking by chemical inhibition or short inter-
fering (si)RNA knockdown of related genes inhibits mTORC1 activation
[28], suggesting that endocytosis is required for this process. A recent
study showed that Rheb stimulates mTOR- and V-ATPase-dependent
signaling required for apical endocytosis in ﬂy epithelial cells [29].
The multi-ligand receptor megalin, which is also required for Rheb-
induced endocytosis, is transcriptionally controlled in a Rheb-
dependent manner. The coupling of protein internalization and degra-
dation, transcriptional regulation of endocytic machinery, and signaling
from extracellular growth factors by lysosomal V-ATPase/mTORC1may
ensure proper nutrient uptake during cell and tissue growth and
prevent nutrient uptake during stress conditions.3.2. Wnt signaling
The Wnt signaling pathway is critical for cell differentiation and
tissue morphogenesis and maintenance in animals from the earliest
stages of embryogenesis to adulthood. It also plays a central role in
establishing the body axis at the peri-gastrulation stage and in embry-
onic cell fate speciﬁcation in both vertebrates and invertebrates. In the
adult, Wnt signaling maintains tissue homeostasis by regulating and
coordinating various cellular events including proliferation, differentia-
tion, polarity, andmigration. In humans, dysregulation ofWnt signaling
leads to diseases such as cancer. For example, colorectal cancer arises
from loss of the tumor suppressor adenomatous polyposis coli (APC),
a negative regulator of Wnt signaling (reviewed in [30]).
Wnt proteins act on target cells by binding to a cell surface receptor
complex formed of Fz (Frizzled, a seven-transmembrane receptor) and
LRP (low-density lipoprotein receptor-related protein, a single-pass
membrane receptor). Downstream signaling networks can be divided
into canonical (Wnt/β-catenin-dependent) and several non-canonical
pathways, including the Wnt/planar cell polarity (PCP) pathway
(Fig. 3a). Critical points of regulation in this signaling cascade are the
disassembly of the protein complex consisting of the Ser/Thr protein
kinase GSK-3β, β-catenin, and scaffold proteins APC and Axin. Within
this complex, β-catenin is constitutively phosphorylated by GSK-3β
and is thus targeted for ubiquitination and proteasomal degradation,
maintaining free β-catenin at a low level in the absence of the Wnt
signaling. The binding of a subset of Wnt ligands (e.g., Wnt3 and
Wnt3a in the gastrulation) to the receptor complex directs the
phosphorylation of the receptor Lrp5/6 by casein kinase 1γ and GSK-
3β. Phosphorylated domain of Lrp5/6 plays two roles: it is a direct
competitive inhibitor of GSK-3β, and it recruits the GSK-3β inhibitor
Axin to the complex. Both activities shut down the β-catenin phosphor-
ylation by GSK-3β, and non-phosphorylated β-catenin is released to
the cytosol and translocates into the nucleus where it activates the
transcription of target genes including the cell cycle checkpoint compo-
nent cyclin D1 and the protooncogene c-Myc.
siRNA-mediated depletion of ATP6ap2—an accessory subunit of V-
ATPase—signiﬁcantly reduces the cellular response to canonical Wnt
signaling [31]. Morpholino antisense RNA-mediated inhibition of
Atp6ap2 in Xenopus tadpoles leads to morphogenetic defects—such as
anterior truncation and disorganization of the central nervous
system—that correspond to those of embryos lacking canonical Wnt
signaling, indicating that Atp6ap2 is linked to this pathway. Further-
more, Atp6ap2 interacts with Lrp5/6, suggesting that V-ATPase
may be part of the Wnt signaling complex. The pharmacological
inhibition of V-ATPase also blocks transmission of the Wnt signal;
thus, ATP catalysis and/or proton translocation appear to be coupled
to signal transduction. This ﬁnding is supported by the observation
that Wnt/β-catenin signaling requires Atp6ap2 in Drosophila [32],suggesting that the requirement for Atp6ap2 in canonicalWnt signaling
is common to both vertebrates and invertebrates.
PCP deﬁnes the polarized orientation of cells along the horizontal
plane of an epithelial sheet and sustains various processes in cells and
tissue. Wnt signaling components—including Frizzled receptors—play
a major role in PCP establishment and maintenance; however, this
pathway is considered to be distinct from canonical Wnt signaling and
triggered by a different class of ligands (e.g., Wnt5) without β-catenin
activation [33,34]. An RNAi-based screen identiﬁed an Atp6ap2 homo-
log that is required for the correct orientation of bristles in Drosophila
wings, an organization that is established by the PCP pathway. Silencing
the other subunits of V-ATPase causes similar defects,with the degree of
severity dependent on the subunit. These observations indicate that like
canonical Wnt signaling, the PCP pathway depends on V-ATPase
function.
Upon Wnt stimulation, canonical and non-canonical signaling
complexes are endocytosed and translocated to early endosomes.
The proton gradient generated by V-ATPase across the endosomal
membrane is essential for LRP phosphorylation. Loss of ATP6ap2
or other V-ATPase subunits causes defects in endosomal trafﬁcking
and/or acidiﬁcation, resulting in the dysregulation of Wnt signaling.
3.3. Notch signaling
Notch signaling is a highly conserved cell–cell communication
pathway that is involved in a variety of processes including pattern
formation during organ development, homeostasis, cell fate determina-
tion, survival, proliferation, and differentiation [35]. Abrogation of
Notch signaling is associated with developmental disorders and often
leads to cancer in human adults [36]. The signaling cascade is initiated
with the binding of the ligand to the single-pass transmembrane
receptor Notch, triggering its proteolytic cleavage by a disintegrin and
metalloproteinase family member followed by γ-secretase (Fig. 3b).
Consequently, the Notch intracellular domain (NICD) is released and
translocates to the nucleus to regulate transcription [35].
The proteolytic processing that activates Notch involves the inter-
nalization of both receptor and ligand and subsequent trafﬁcking to
endomembrane compartments.Drosophilamutants that show impaired
endocytic trafﬁcking and acidiﬁcation due to altered V-ATPase activity
have dysregulated Notch signaling [23,37]. On the other hand, accumu-
lation of acidic vesicles in aDrosophila Lglmutant induced the upregula-
tion of Notch signaling [38]. Although the underlyingmechanisms are as
yet unclear, it was proposed that V-ATPase-dependent acidiﬁcation
creates an environment favorable for Notch signaling in multiple indi-
rect steps, including the regulation of trafﬁc between early and late
endosomes, establishment of low luminal pH for optimal γ-secretase
activity, and control of the maturation and localization of γ-secretase.
In mammalian systems, βA3/A1-crystallin—a major structural protein
of the lens—exhibits an unusual function in rat optic nerve astrocytes:
mutations in βA3/A1-crystallin modulate Notch signaling in these cells
by altering V-ATPase activity [39]. Additionally, pharmacological inhibi-
tion or knockdown of V-ATPase results in the failure of endothelial cell
migration accompanied by a reduction in vascular endothelial growth
factor trafﬁcking and activation of Rac1 and Notch signaling [40,41].
Notch signaling is also regulated in signal-sending cells. Notch
ligands are single-pass transmembrane proteins of the Delta/Serrate/
LAG-2 (DSL) family that bind to the extracellular domain of the recep-
tor. DSL ligand activity depends on monoubiquitination by E3 ubiquitin
ligases, which is a prerequisite for endocytosis [35]. Loss of E3 function
results in the accumulation of DSL ligands at the cell surface and
prevents their endocytosis and activation. The activity of ubiquitin
ligases is regulated at the post-transcriptional level by the kinase
partitioning defective (PAR)-1, which participates in the establishment
of apico-basal cell polarity [42]. Meanwhile, PAR-1 activity and subcel-
lular localization are regulated by atypical protein kinase (aPKC), a
core component of the PAR-3/PAR-6/aPKC complex that regulates
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a close link between cell polarity and cell fate determination.
Notch signaling is dysregulated in many diseases. For instance,
oncogenic Notch activation underlies T cell acute lymphoblastic
leukemia and breast and lung cancers. In particular, metastatic cancers
are characterized by higher acidity due to increased V-ATPase
activity [44,45]. Pharmacological blockade of V-ATPase with
baﬁlomycin, a V-ATPase-speciﬁc inhibitor, affects Notch signaling in
normal cells as well as in cancerous cells with oncogenic Notch activi-
ty [46]. Therefore, agents thatmodulate V-ATPase activity are promising
for cancer treatment.
3.4. GTP-binding protein-coupled receptor (GPCR) signaling
GPCRs are seven-transmembrane domain receptors constituting a
large protein family that senses molecules outside the cell and activates
intracellular signal transduction cascades to induce cellular responses.
The parathyroid hormone (PTH) receptor (PTHR) is one type of GPCR
expressed in various tissues that regulates calciumand phosphate levels
in serum. Acidic luminal pH accelerates the rate of dissociation of PTH
from PTHR and directly affects the magnitude and duration of ligand-
mediated cAMP production [47]. PTH induces the phosphorylation of
the V-ATPase a subunit via cAMP-dependent protein kinase (PKA),
which positively regulates the catalytic activity of the pump. This in
turn stimulates the dissociation of PTH from PTHR, providing negative
feedback for the signaling.
The regulatorymechanism for PTH is similar to that of cholera toxin,
which catalyzes ADP ribosylation of GαS and induces persistent activa-
tion of the Gs-cAMP-PKA axis, thereby increasing endosomal H+ trans-
port. Cholera toxin administration leads to the transient recruitment of
the small GTPase Arf6, a cofactor for full ADP-ribosylation of GαS [48]. It
was also reported that Arf6 is involved in the formation of clathrin-
coated vesicles derived from the plasma membrane and from
endosomes. Cytosolic Arf6 is recruited to endosomal membrane in an
intra-endosomal acidic pH-dependent manner via direct interaction
with the V-ATPase c subunit. Disruption of this interaction results in
the inability of early endosome to form carrier vesicles, leading to a
blockage of endocytic trafﬁcking between early and late endosomes
[24]. Therefore, the regulation of PTH or other hormones may involve
mechanisms that are linked to endocytosis and endosomal acidiﬁcation.
3.5. V-ATPase function in tissue organization
As discussed above, V-ATPase is implicated in multiple signaling
pathways and its deﬁciency can therefore have pleiotropic effects that
reﬂect the general failure of endocytosis or membrane recycling rather
than a direct involvement of the enzyme in speciﬁc signaling pathways.
For instance, V-ATPase-dependent proton transport has been shown to
be directly involved in the earliest step of signal transduction cascades:
tail regeneration in frog tadpoles is inhibited by pharmacological inhibi-
tion or knockdown of V-ATPase and the NaV1.2 sodium channel. Epi-
static analyses suggest that plasma membrane-localized V-ATPase
drives proton efﬂux and the conductance of sodium via the NaV1.2
channel, which activates cytoplasmic sodium-dependent protein kinase
to induce downstream signaling (including Notch) and target gene
expression. Importantly, V-ATPase activation occurs shortly after
amputation; the membrane potential is then altered, followed by the
expression of variousmorphogenetic genes regulated byWnt, ﬁbroblast
growth factor, bone morphogenetic protein, and Notch signaling.
V-ATPase is distributed asymmetrically in fertilized Xenopus eggs
and later directs the left–right (L–R) asymmetry of the body plan.
Disrupting V-ATPase activity results in the randomization of L–R
patterning in frog embryos [49,50]. Genetic mutations in V-ATPase
subunits cause malformation of Kupffer's vesicle (KV), a ﬂuid-ﬁlled
organ formed by mono-ciliated epithelium in ﬁsh embryos that estab-
lishes L–R body axis in teleosts. In mouse, ﬂuid ﬂow in the embryonicnode—also formed by mono-ciliated epithelium—is involved in L–R
body axis determination. Ciliogenesis is regulated by the PCP pathway
[51], which involves V-ATPase. It remains to be determined whether
the loss of V-ATPase function causes disorganization of mono-ciliated
epithelium in KV or the node, or whether it primarily affects membrane
potential, in turn leading to the randomization of left and right sides.
Indeed, one study showed that inhibiting the vesicle transport protein
sorting nexin (SNX)10 had this effect [52]. SNX10 interacts with the
V-ATPase D subunit and recruits the proton pump complex to the
base of the cilium; like SNX10, V-ATPase is required for organizing
cilia in cultured cells as well as in ﬁsh embryos [52]. These ﬁndings
suggest that V-ATPase activity is involved in the establishment of L–R
asymmetry during early vertebrate development.
To date, there is no evidence that V-ATPase is involved either directly
or indirectly in nodal ﬂow or in L–R asymmetry establishment in mam-
mals, although recent studies have demonstrated that Notch signaling
controls Wnt expression in the node and that Wnt/β-catenin signaling
is required for establishing L–R asymmetry [53]. A null mutation in
Atp6v0c, the sole gene encoding the V-ATPase complex, causes develop-
mental defects at an earlier stage (embryonic day 5) [15] than the
establishment of L–R asymmetry (day 8), precluding the investigation
of the role of V-ATPase in the latter process. Generating conditional
alleles and examining the distribution and expression of the V-ATPase
complex in embryos at different developmental stages can provide
insight into this question.
4. Summary
Signaling pathways including Wnt (both canonical and non-
canonical), Notch, and mTOR are closely linked to growth regulation.
It becomes obvious that the V-ATPase function is more directly involve
in these signaling pathways. In theWnt and mTOR pathways, in partic-
ular, the lines of evidence suggest that V-ATPase is an intrinsic part of
signaling mechanisms, i.e., as the part of receptor complex, or as the
regulator for the molecular switch Rag GTPases. Emerging evidence
indicates that V-ATPase-regulated endocytic organelles and their
trafﬁcking function, which is essential for the Notch–Delta cascade
and the GPCR signaling. Furthermore, electrochemical potential modu-
lated by the V-ATPase and other ion transporters may constitute ele-
mentary steps in the mechanism of signal transduction. These aspects
have emerged rather new, thus there remains many unanswered ques-
tions for depicting the whole scheme. Future studies on the regulatory
mechanism of the V-ATPase and the signaling network may provide
insight for therapeutic approach to cancer.
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